0
Article |

Subspecificities of the Australia Antigen Complex FREE

George L. Le Bouvier, MD
[+] Author Affiliations

Reprint requests to Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College St, New Haven, Conn 06510 (Dr. Le Bouvier).


Am J Dis Child. 1972;123(4):420-424. doi:10.1001/archpedi.1972.02110100152059.
Text Size: A A A
Published online

Australia (Au) antigen,1 also known as serum hepatitis (SH) antigen and hepatitis-associated antigen (HAA), appears in the serum during infection with the agent, or one of the agents, of long-incubation (type B) hepatitis.2,3 Australia antigen is carried on characteristic spherical and tubular particles 20 nm in diameter,4 which are most probably fragments of a viral lipoprotein envelope, related in structure and antigenic specificity to the outer coat of the relatively infrequent 42-nm viruslike particles seen in certain Au-antigen-positive (Au+) sera.5 Whether or not these larger particles represent the actual "hepatovirions" is a matter of continuing debate.

Repeated indications over the past two years suggest that Au antigen is not a single simple entity, and that anti-Au antisera may contain antibody molecules of different specificities. Levene and Blumberg were the first to study these reactions6: they described a common antigenic specificity, "a," shared Au+ sera; and two additional, apparently allternative, specificities,

REFERENCES

Blumberg BS, Alter HJ, Visnich S:  A "new" antigen in leukemia sera . JAMA 191:541-546, 1965;.
Prince AM:  An antigen detected in the blood during the incubation period of serum hepatitis . Proc Nat Acad Sci USA 60:814-821, 1968;.
Giles JP, McCollum RW, Berndtson LW Jr, et al:  Relation of Australia/SH antigen to the Willowbrook MS-2 strain . New Eng J Med 281:119-122, 1969;.
Bayer ME, Blumberg BS, Werner B:  Particles associated with Australia antigen in the sera of patients with leukemia, Down's syndrome and hepatitis . Nature 318:1057-1059, 1968;.
Dane DS, Cameron CH, Briggs M:  Virus-like particles in the serum of patients with Australia-antigen-associated hepatitis . Lancet 1:695-698, 1970;.
Levene C, Blumberg BS:  Additional specificities of Australia antigen and the possible identification of hepatitis carriers . Nature 221:195-196, 1969;.
Le Bouvier GL:  The heterogeneity of Australia antigen . J Infect Dis 123:671-675, 1971;.
Kim CY, Tilles JG:  Immunologic and electrophoretic heterogeneity of hepatitisassociated antigen . J Infect Dis 123:618-628, 1971;.
Le Bouvier GL, McCollum RW:  Australia (hepatitis-associated) antigen: Physicochemical and immunological characteristics . Adv Virus Res 16:357-396, 1970;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Blumberg BS, Alter HJ, Visnich S:  A "new" antigen in leukemia sera . JAMA 191:541-546, 1965;.
Prince AM:  An antigen detected in the blood during the incubation period of serum hepatitis . Proc Nat Acad Sci USA 60:814-821, 1968;.
Giles JP, McCollum RW, Berndtson LW Jr, et al:  Relation of Australia/SH antigen to the Willowbrook MS-2 strain . New Eng J Med 281:119-122, 1969;.
Bayer ME, Blumberg BS, Werner B:  Particles associated with Australia antigen in the sera of patients with leukemia, Down's syndrome and hepatitis . Nature 318:1057-1059, 1968;.
Dane DS, Cameron CH, Briggs M:  Virus-like particles in the serum of patients with Australia-antigen-associated hepatitis . Lancet 1:695-698, 1970;.
Levene C, Blumberg BS:  Additional specificities of Australia antigen and the possible identification of hepatitis carriers . Nature 221:195-196, 1969;.
Le Bouvier GL:  The heterogeneity of Australia antigen . J Infect Dis 123:671-675, 1971;.
Kim CY, Tilles JG:  Immunologic and electrophoretic heterogeneity of hepatitisassociated antigen . J Infect Dis 123:618-628, 1971;.
Le Bouvier GL, McCollum RW:  Australia (hepatitis-associated) antigen: Physicochemical and immunological characteristics . Adv Virus Res 16:357-396, 1970;.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.